2x Champion Trader Goes SHORT
The wild statistics are flying now. At the depths of the price action on Friday, the bearish tape was as bad as any seen since the COVID lows.
2% corrections in the Dow Jones Industrial Average, NASDAQ and S&P 500 all signaled broad-based selling and the obliteration of just about every sector.
Nothing was left unscathed. » Read more about: 2x Champion Trader Goes SHORT »
Read More
Will Berkshire Be a $1 Trillion Company?
Berkshire Hathaway (BRK.A) stock price is among the most expensive in the world, yet the company’s valuation arguably leaves a lot of room to the upside still. While Cathie Wood’s ARK was stealing headlines over the past couple of years for her disruptive innovation thematic investments, Berkshire Hathaway share price crept up quietly to ultimately outperform ARKK over the past 2 years.
» Read more about: Will Berkshire Be a $1 Trillion Company? »
Read MoreThe ONLY Metaverse Stock To Own For 10 Years
When Meta — the company formerly known as Facebook — announced its intent to transition its attention away from social media and toward the Metaverse, this massive shift in focus immediately grabbed the attention of retail investors and traders alike. Hoping to get in on the ground level of this buzzworthy new iteration of the Internet,
» Read more about: The ONLY Metaverse Stock To Own For 10 Years »
Read More
How Moderna Won the Vaccine Wars
Traders looking to invest in vaccine stocks faced a difficult decision at the start of the vaccine rollout in late 2020 and early 2021: which vaccine stock would be the best bet in the months and years to come? With Pfizer and BioNTech, Johnson & Johnson and Moderna all becoming available at once, there was no way to know for sure which investment would yield the greatest returns.
» Read more about: How Moderna Won the Vaccine Wars »
Read More
Golden Cross Gives Bulls Green Light?
One of the more unexpected tailwinds for healthcare stocks in recent years has been the weight-loss frenzy brought about most notably by Ozempic.
Novo Nordisk’s drug was such a hit that the share price soared by 62% over the past year alone. Yet it’s not the only game in town. Eli Lilly’s weight-loss drug,
» Read more about: Golden Cross Gives Bulls Green Light? »
Read MoreThe Burst
Market Commentary: Is $1 Billion A Year Enough?
Imagine I could reveal to you a stock that generates a cool $1 billion of income a year on revenues of $4.4 billion? That’s right a company that is so profitable it regularly reports 10-figures of profits, and now what if I told you the market values it at less than 1x sales, would you be interested?
» Read more about: Market Commentary: Is $1 Billion A Year Enough? »
Read MoreThe Spotlight
The Next Trillion Dollar Company?
The economic ups and downs of 2020 put entire industries underwater, but the technology sector thrived. There was instant demand from consumers, educational institutions and businesses of all sizes for cloud-based services, which drove up revenue—and share prices—for companies like Amazon, Netflix, Zoom and Peloton.
Of course, that growth wasn’t limited to US-based companies.
» Read more about: The Next Trillion Dollar Company? »
Read MoreThe Daily
Baird Raises Apple (AAPL) PT Ahead of Earnings; Analysts Cite Upgrade Tailwinds
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!
AI is eating the world—and the machines behind it are ravenous.
Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy.
» Read more about: Baird Raises Apple (AAPL) PT Ahead of Earnings; Analysts Cite Upgrade Tailwinds »